191 related articles for article (PubMed ID: 37777511)
1. A CK2 and SUMO-dependent, PML NB-involved regulatory mechanism controlling BLM ubiquitination and G-quadruplex resolution.
Liu S; Atkinson E; Paulucci-Holthauzen A; Wang B
Nat Commun; 2023 Sep; 14(1):6111. PubMed ID: 37777511
[TBL] [Abstract][Full Text] [Related]
2. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
3. SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.
Brown JR; Conn KL; Wasson P; Charman M; Tong L; Grant K; McFarlane S; Boutell C
J Virol; 2016 Jul; 90(13):5939-5952. PubMed ID: 27099310
[TBL] [Abstract][Full Text] [Related]
4. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
5. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
[TBL] [Abstract][Full Text] [Related]
6. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
7. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
8. Arkadia (RING Finger Protein 111) Mediates Sumoylation-Dependent Stabilization of Nrf2 Through K48-Linked Ubiquitination.
McIntosh DJ; Walters TS; Arinze IJ; Davis J
Cell Physiol Biochem; 2018; 46(1):418-430. PubMed ID: 29597191
[TBL] [Abstract][Full Text] [Related]
9. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
11. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
13. The Viral SUMO-Targeted Ubiquitin Ligase ICP0 is Phosphorylated and Activated by Host Kinase Chk2.
Hembram DSS; Negi H; Biswas P; Tripathi V; Bhushan L; Shet D; Kumar V; Das R
J Mol Biol; 2020 Mar; 432(7):1952-1977. PubMed ID: 32001251
[TBL] [Abstract][Full Text] [Related]
14. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
15. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
16. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
17. Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1.
Lussier-Price M; Wahba HM; Mascle XH; Cappadocia L; Bourdeau V; Gagnon C; Igelmann S; Sakaguchi K; Ferbeyre G; Omichinski JG
Nucleic Acids Res; 2022 Aug; 50(14):8331-8348. PubMed ID: 35871297
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
[TBL] [Abstract][Full Text] [Related]
19. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
20. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
Li C; Peng Q; Wan X; Sun H; Tang J
J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
